Prospective Study Of Ophthalmologic Function In Patients Receiving Linezolid For Six Weeks Or Greater.
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2015
At a glance
- Drugs Linezolid (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Registrational
- Sponsors Pfizer
- 25 Jun 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 28 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014.